European Journal of Surgical Oncology · 2019 · 13 citations · 21 references
MedicineOncologySurgeryMetastasisOncologic SurgerySurgical OncologyBiliary Tract CancerHepatobiliary CancerLiver CancerLymph Node MetastasisLymphatic MetastasisMalignant NeoplasmsBiliary Tract Cancer Liver MetastasisIntrahepatic Cholangiocarcinoma SurgeryLymph Node Metastasis PrognosisRecurrence-free SurvivalRegional Lymph Node InvolvementTertiary CentersTnm Staging System
BACKGROUND: The clinical implication of lymph node (LN) dissection of intrahepatic cholangiocarcinoma (ICCA) is still controversial, and LN metastasis (LNM) based on tumor site has not been confirmed yet. METHODS: Patients who underwent curative-intent surgery at 10 tertiary referral centers were identified and divided into peripheral (PP) and near second confluence level tumor (NC) groups on the basis of the distance from the second confluence and oncological outcomes were compared. RESULTS: Of 179 patients, 121 patients with LND were divided into the NC (n = 89) and PP groups (n = 32) on the basis of 4.5 cm from the second confluence. NC group showed higher LNM rate than PP group (46.1 vs 21.9%, p = 0.016) and NC was a risk factor for LNM (odds ratio: 4.367; 95% confidence interval: 1.234-15.453, p = 0.022). The 5-year overall survival (OS) rate (38.0% vs. 27.8%, p = 0.777) and recurrence-free survival (RFS) rates (22.8% vs. 25.8%, p = 0.742) showed no differences between the PP and NC groups. In the NC group, N1 patients showed worse 5-year OS (12.7% vs 39.0%, p = 0.004) and RFS (8.8% vs 28.6%, p = 0.004) than the N0 patients. In the PP group, discordant results in 5-year OS (48.9% vs. 50.0%, p = 0.462) and RFS (41.3% vs. 0%, p = 0.056) were found between the N0 and N1 patients. CONCLUSION: The NC group was an independent risk factor for LNM and LNM worsened prognosis in NC group for ICCA. In the PP group, LND should not be omitted because of high LNM rate and insufficient oncologic evidence.
21
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
John Bridgewater, Peter R. Galle, Shahid A. Khan et al. · Journal of Hepatology · 2014 · 1.5K citations
Medicine, Oncology, Pathobiology +11
Gallbladder Cancer: expert consensus statement
Thomas A. Aloia, Nicolás Jarufe, Milind Javle et al. · HPB · 2015 · 467 citations · Full text
Sae-Byeol Choi, Kyung Sik Kim, Jin‐Young Choi et al. · Annals of Surgical Oncology · 2009 · 312 citations · Full text